Latest Market News

Godolphin Resources has significantly upgraded its Lewis Ponds deposit, increasing total tonnage by 78% and gold content by 34%, setting the stage for an upcoming scoping study.

Symal Group has locked in a $300 million revolving debt facility with major Australian banks, enhancing its financial flexibility to support strategic growth and acquisitions.

Oliver’s Real Food reported a notable 6.5% rise in same-store sales for November 2025 alongside a 22% reduction in expenses, signaling improved operational efficiency. Despite a slight revenue dip year-to-date, the company’s profitability metrics show encouraging signs as it heads into the holiday season.

Future Metals NL has completed strategic planning that enhances its flagship Panton PGM Project’s value, driven by a 35% rise in platinum group metal prices and expanded exploration programs. The company is also advancing infrastructure options and strengthening its management team to accelerate development.

Fortescue Ltd has announced a binding agreement to acquire the remaining 64% of Alta Copper, gaining full control of the Cañariaco Copper Project in Peru. The deal values Alta Copper at C$139 million and aligns with Fortescue’s expanding copper strategy.

Trek Metals has identified a significant high-grade manganese discovery at its Christmas Creek Project, supported by strong gravity anomalies indicating a large concealed mineralised system. Drill planning is underway to test these compelling targets.

Far East Gold has confirmed and extended high-grade gold mineralisation at its Sua prospect in Papua, Indonesia, with recent drill results revealing new bonanza-grade zones and promising resource potential.

DigiCo Infrastructure REIT has announced a 6.0 cents per security distribution for the half-year ending December 2025, reflecting steady income from its expanding data centre portfolio.

Ovanti’s US payments brand Flote has partnered with cloud-native platform Gr4vy to launch scalable, responsible buy now pay later solutions in the US market starting 2026.

Biome Australia has initiated its first human clinical trial for the proprietary probiotic strain Lactobacillus plantarum BMB18, aiming to validate its benefits for digestive and mood-related symptoms.

Imricor Medical Systems has secured Institutional Review Board approval for the University of Virginia Health to join its VISABL-AFL clinical trial, marking a key expansion in the US. Procedures are set to begin early next year, supporting Imricor’s progress toward FDA approval and commercialisation.

AusQuest and South32 have extended their Strategic Alliance Agreement for two more years, securing continued funding and collaboration on Australian copper and zinc projects. South32 will fund exploration to advance projects to drill-ready status and can earn up to 80% interest through staged investments.